A. Darrow

发表

Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening

Zina Itkin, Mary Jo Wildey, Sergey E. Ilyin, 2003, Journal of biomolecular screening.

Protease‐Activated Receptor‐2 (PAR‐2) Is Present in the Rat Hippocampus and Is Associated with Neurodegeneration

M. D'Andrea, P. Andrade-Gordon, A. Darrow, 1997, Journal of neurochemistry.

Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1.

W. Fung-Leung, K. Ngo, R. Ye, 1999, The Journal of pharmacology and experimental therapeutics.

Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes.

C. Derian, P. Andrade-Gordon, R. Scarborough, 1995, Proceedings of the National Academy of Sciences of the United States of America.

High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity

M. Connelly, J. Linders, Charles D Smith, 2010, Journal of Lipid Research.

Mechanisms of Protease-activated Receptor-4 Actions in Cardiomyocytes

A. Sabri, S. Steinberg, P. Andrade-Gordon, 2003, The Journal of Biological Chemistry.

Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.

R. Rickles, S. Strickland, A. Darrow, 1988, The Journal of biological chemistry.

A novel fluorogenic substrate for the measurement of endothelial lipase activity

M. Connelly, I. Deckman, Shariff S Bayoumy, 2011, Journal of Lipid Research.

Differentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells

R. Rickles, S. Strickland, A. Darrow, 1989, Molecular and cellular biology.

Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates

M. D'Andrea, M. Nedelman, C. Derian, 2003, Journal of Pharmacology and Experimental Therapeutics.

Isolation of novel murine maternal mRNAs regulated by cytoplasmic polyadenylation.

F. Sallés, S. Strickland, A. Darrow, 1992, Genes & development.

Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors.

H. Zhang, A. Sabri, S. Steinberg, 2000, Circulation research.

Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.

M. D'Andrea, C. Derian, D. McComsey, 2001, The Journal of pharmacology and experimental therapeutics.

In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver

S. Strickland, L. Pecorino, A. Darrow, 1991, Molecular and cellular biology.

Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation

R. Rickles, S. Strickland, L. Pecorino, 1990, Molecular and cellular biology.

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.

C. Derian, D. McComsey, B. Maryanoff, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues

S. M. Baker, D. Leturcq, L. Brass, 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Transient translational silencing by reversible mRNA deadenylation

D. Belin, A. Stutz, J. Vassalli, 1992, Cell.

Biological Consequences of Thrombin Receptor Deficiency in Mice

P. A. Peterson, W. Fung-Leung, R. Ye, 1996, Thrombosis and Haemostasis.

Maintenance and use of F9 teratocarcinoma cells.

R. Rickles, S. Strickland, A. Darrow, 1990, Methods in enzymology.

A novel serine protease predominately expressed in macrophages.

M. D'Andrea, J. Qi, A. Darrow, 2003, The Biochemical journal.

Preimplantation mouse embryos express a cell surface receptor for tissue-plasminogen activator.

W. Richards, S. Strickland, P. Carroll, 1993, Development.

The Nucleotide-binding Site of Human Sphingosine Kinase 1*

M. Vadas, C. Bagley, B. Wattenberg, 2002, The Journal of Biological Chemistry.

NMR‐based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein‐E deficient mice

Gregory C Leo, G. Leo, Andrew L Darrow, 2009, Magnetic resonance in chemistry : MRC.

Transcription Factor SplIsImportant forRetinoic Acid-Induced Expression oftheTissue Plasminogen Activator Geneduring F9Teratocarcinoma Cell Differentiation

L. Pecorino, A. Darrow, 1990 .

InVitro Analysis oftheTissue Plasminogen Activator Promoter Reveals aGC Box-Binding Activity Present inMurineBrainbut Undetectable inKidneyandLiver

L. Pecorino, A. Darrow, 1991 .

A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice.

G. Leo, D. Hlasta, H. Xin, 2013, Bioorganic & medicinal chemistry letters.

Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.

D. McComsey, B. Maryanoff, C. E. Smith, 2001, Archives of biochemistry and biophysics.

Mer Receptor Tyrosine Kinase Signaling Participates in Platelet Function

Quan Li, C. Derian, B. Damiano, 2004, Arteriosclerosis, thrombosis, and vascular biology.

An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes.

M. Vadas, C. Derian, S. Pitson, 2004, Analytical biochemistry.

Integrated expressional analysis: application to the drug discovery process.

C. Plata-salamán, M. D'Andrea, S. Ilyin, 2005, Methods.

Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates

M. D'Andrea, M. Nedelman, C. Derian, 2003, Journal of Pharmacology and Experimental Therapeutics.